Positive late-breaking clinical trial data for the ekosonic™ endovascular system presented at viva21

Las vegas and marlborough, mass., oct. 5, 2021 /prnewswire/ -- today, boston scientific (nyse: bsx) announced positive results for the ekosonic™ endovascular system (ekos system) during a late-breaking clinical trial presentation at the vascular interventional advances (viva) meeting in las vegas.
BSX Ratings Summary
BSX Quant Ranking